POC Rapid Assays

Rapid Syphilis Testing Access Expanded

Labcorp and NOWDiagnostics have partnered to distribute free First to Know Syphilis Test kits to public health organizations nationwide.

POC Rapid Assays

Finger-Prick Test Developed for Common Undiagnosed STI

A quick, affordable diagnostic finger-prick test may help curb one of the most prevalent but least discussed sexually transmitted infections.

POC Rapid Assays

Is At-Home Testing the Key to Future Pandemic Response?

The pandemic changed many aspects of American society, including the acceptance and prevalence of at-home testing.

Optical Method for Rapid COVID Detection Obtains 100% Sensitivity

Feb 18, 2022 | Covid 19, POC Rapid Assays

A new method has obtained a sensitivity of 100% and a specificity of 87.5% in the detection of SARS-CoV-2 in nasopharyngeal exudate from symptomatic people.

Handheld COVID Breathalyzer Could Allow Mass Screening in Public Spaces

Feb 3, 2022 | Covid 19, POC Rapid Assays

Researchers developed a prototype, handheld “breathalyzer” that can sensitively and accurately diagnose COVID-19 in less than 5 minutes.

COVID Control: How Northeastern University Built an In-House Testing Lab from Scratch

Dec 30, 2021 | Covid 19, Immunoassay Reagents & test Kits, POC Rapid Assays

Boston-based Northeastern University fully reopened in Fall 2021 thanks to a rigorous COVID testing program and an in-house laboratory.

Biden outlines new Omicron strategy, will order 500 million at-home tests for Americans

Dec 21, 2021 | Covid 19, POC Rapid Assays

President Joe Biden outlined a new plan to combat the surging Omicron variant, including a plan to deploy millions of at-home tests.

Saliva May Be an Easier Alternative for Rapid COVID-19 Tests

Nov 23, 2021 | Covid 19, POC Rapid Assays

A new study on rapid COVID-19 testing is investigating whether a saliva-based rapid antigen testing is more effective than the more common PCR tests.

FDA Authorizes Additional Indication for BinaxNOW COVID-19 Self Test

Nov 10, 2021 | Covid 19, POC Rapid Assays

The FDA reissued the EUA for the BinaxNOW COVID-19 Antigen Self Test as a single test without a prescription for people with COVID-19 symptoms.

FDA Grants Emergency Use Authorization for Rapid SPERA COVID-19 Ag Test

Nov 5, 2021 | Covid 19, POC Rapid Assays

The FDA has issued an EUA for the SPERA COVID-19 Ag Test, a rapid lateral flow immunoassay from Xtrava Health designed for use at the point of care.

LumiraDx’s COVID-19 Antigen Test Expanded to Include Screening of Asymptomatic Individuals

Nov 2, 2021 | Covid 19, POC Rapid Assays

LumiraDx announced that the intended use for its FDA EUA-authorized SARS-CoV-2 Antigen Test has been expanded to include asymptomatic individuals.

Strategic COVID-19 Testing Could Prevent Distancing, Shutdowns

Nov 1, 2021 | Covid 19, POC Rapid Assays

Making diagnostic tests for SARS-CoV-2 faster or more available could reduce reliance on costly interventions, such as distancing and shutdowns.

Dotz Nano to Showcase Mega-Diagnostic Platform

Oct 28, 2021 | Covid 19, POC Rapid Assays

Dotz Nano will introduce its Mega-Diagnostic Platform for en masse, rapid diagnosis of COVID-19 at the point of care.

BD Announces Shipments of OTC Rapid COVID-19 Test

Oct 27, 2021 | Covid 19, POC Rapid Assays

Shipments are now available for the BD Veritor At-Home COVID-19 Test, an over-the-counter COVID-19 rapid antigen test.

Intrivo Launches Rapid COVID-19 Antigen Self-Test

Oct 20, 2021 | Covid 19, POC Rapid Assays

Intrivo has launched On/Go, an at-home, rapid COVID-19 antigen self-test designed to deliver results with 95% accuracy in just 10 minutes.

Cue Health To Provide COVID-19 Testing For 2021-22 NBA Season

Oct 15, 2021 | Covid 19, POC Rapid Assays

Cue Health Inc.and the NBA have announced that Cue will serve as the league’s Official Home and Point of Care COVID Test for the 2021-22 season.

White House announces $1 billion purchase of rapid, at-home coronavirus tests

Oct 7, 2021 | Covid 19, POC Rapid Assays

The Biden Administration will buy $1 billion worth of rapid at-home PCR tests, aimed at increasing access to testing to drive down infections of SARS-CoV-2.